CIK 0001323885 · Large accelerated filer
AtriCure, Inc.
Sign in to watch- Ticker
- ATRC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 341940305
- Phone
- 513-755-4100
- Business address
- 7555 INNOVATION WAY, MASON, OH, 45040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,315,656
- in 7 filings, $1.4M under 10b5-1 plans
Net −$2,315,656. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | JOHNSON B KRISTINE Director | Sale | −2,452 | $58.48 | $143K | 53,502 |
| 2026-11-04 | Privitera Salvatore Chief Technical Officer | Sale 10b5-1 | −8,404 | $65.00 | $546K | 134,341 |
| 2026-09-23 | Privitera Salvatore Chief Technical Officer | Sale 10b5-1 | −4,519 | $60.00 | $271K | 142,745 |
| 2026-09-11 | GROVES REGINA E Director | Sale | −5,313 | $54.22 | $288K | 34,546 |
| 2026-09-08 | Privitera Salvatore Chief Technical Officer | Sale 10b5-1 | −3,657 | $55.00 | $201K | 147,264 |
| 2026-09-02 | Privitera Salvatore Chief Technical Officer | Sale 10b5-1 | −7,763 | $52.50 | $408K | 150,921 |
| 2026-08-24 | Dahlquist Karl S. Chief Legal Officer | Sale | −9,370 | $48.89 | $458K | 87,319 |
| 2026-08-05 | Yuen Maggie Director | Sale | −3,500 | $38.42 | $134K | 14,015 |
| 2026-08-05 | Prange Karen Director | Sale | −3,564 | $38.80 | $138K | 22,809 |
| 2026-07-30 | CARREL MICHAEL H President, CEO, & Director | Gift | −700 | 778,434 | ||
| 2026-07-30 | CARREL MICHAEL H President, CEO, & Director | Gift | −4,000 | 774,434 | ||
| 2026-07-29 | Noznesky Justin J Chief Mktg & Strategy Officer | Sale | −6,182 | $38.80 | $240K | 100,219 |
| 2026-07-28 | Doraiswamy Vinayak Chief Scientific Officer | Sale | −6,000 | $38.88 | $233K | 86,511 |
| 2026-07-28 | WEHRWEIN SVEN Director | Option exercise | +25,000 | $19.95 | $499K | 65,518 |
| 2026-07-28 | WEHRWEIN SVEN Director | Sale | −25,000 | $37.84 | $946K | 40,518 |
| 2026-07-28 | WEHRWEIN SVEN Director | Option exercise · Non-qualified Stock Option (right to buy) | −25,000 | 0 | ||
| 2026-06-30 | Doraiswamy Vinayak Chief Scientific Officer | Grant or award | +636 | $23.78 | $15K | 92,511 |
| 2026-06-30 | Dahlquist Karl S. Chief Legal Officer | Grant or award | +636 | $23.78 | $15K | 96,689 |
| 2026-06-30 | Seith Douglas J Chief Operating Officer | Grant or award | +527 | $23.78 | $13K | 229,867 |
| 2026-06-30 | Privitera Salvatore Chief Technical Officer | Grant or award | +636 | $23.78 | $15K | 158,684 |
Page 1 of 8 · 147 trades